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CASE REPORT
Organizing pneumonia as the first 
manifestation of anti-synthetase syndrome
S. M. Thanuja Nilushi Priyangika*, W. G. S. G. karunarathna, Isurujith Liyanage, Methsala Gunawardana, 
Sumeda Udumalgala, Chamith Rosa and Aruna Kulatunga
Abstract 
Background: Anti-synthetase syndrome associated interstitial lung disease can occur either simultaneously, before, 
or after the development of polymyositis/dermatomyositis. Histology of interstitial lung disease can be nonspecific 
interstitial pneumonia, usual interstitial pneumonia, diffuse alveolar damage, organizing pneumonia. Organizing 
pneumonia associated anti-synthetase syndrome is a rare finding especially as the first manifestation.
Case presentation: We report a 41 year old male patient who presented with organizing pneumonia and 2 years 
following the onset, developed polymyositis with anti-JO-1 antibody positivity.
Conclusion: It is important to screen patients with organizing pneumonia for anti-synthetase syndrome which can 
be manifested later.
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Background
Polymyositis (PM) and dermatomyositis (DM) are sys-
temic inflammatory disorders predominantly affecting 
skeletal muscles and skin respectively. They also affect 
the oesophagus, lungs and the heart. Pulmonary involve-
ment is common, and may be a major cause of morbid-
ity. It commonly manifests as an interstitial lung disease 
(ILD) which may progress rapidly and be fatal [1]. Anti-
synthetase syndrome is characterized by serum antibod-
ies to aminoacyl-tRNA synthetase and constellation of 
manifestations, including fever, PM-DM, ILD, arthritis, 
“mechanics hands”. Organizing pneumonia (previously 
known as bronchiolitis oblitarence with organizing 
pneumonia/BOOP) is rarely reported in these patients, 
as the first presenting symptom [2–4]. We report a case 
of anti-synthetase syndrome initially presented to us 
with organizing pneumonia and 2 years later presented 
as polymyositis.
Case presentation
A 41-year-old male with uncomplicated type 2 diabetes 
mellitus presented with fever and progressive exertional 
dyspnoea for 1  week. His respiratory system examina-
tion revealed bilateral fine end-inspiratory crackles. High 
resolution computed tomography (HRCT) of the chest 
showed sub pleural patchy air space consolidation and 
ground glass opacification with air bronchogram in bilat-
eral basal regions with sparing of upper and middle zones 
(Fig.  1). Trans-bronchial lung biopsy showed alveoli 
which are filled with sheets of foamy macrophages with 
few scattered neutrophils and fibrotic plugs. Alveolar 
septae appeared thickened. A diagnosis of OP was made 
based on these findings. During this presentation he did 
not complain any muscle pain, weakness, joint pains or 
skin thickening in fingers. He was successfully managed 
with steroids, which were tailed off after 10 months. Sub-
sequently he was lost to follow up as he failed to show-
up at scheduled clinic visits. However 2  years later, he 
presented with a 2  week history of progressively wors-
ening proximal muscle pain mainly involving the neck 
and upper limbs. He also had low-grade fever with no 
skin rashes, arthralgia or respiratory symptoms. There 
was no history of exposure to dust or medication except 
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metformin. On examination both upper and lower 
limbs were neurologically normal except proximal mus-
cle tenderness. His respiratory system examination was 
unremarkable.
Laboratory investigations revealed creatine phosphoki-
nase (CPK) 14820 U/L, C reactive protein (CRP) 110 mg/
dL, erythrocyte sedimentation rate (ESR) 70  mm/1st  h, 
thyroid stimulating test (TSH) 1.84  mIU/L and free T4 
0.94 ng/dL. The electro-myography (EMG) did not show 
evidence of myositis or myopathy. Anti-Jo-1 antibody 
and the anti-nuclear-antibody were positive. Deltoid 
muscle biopsy (Fig.  2) and magnetic resonance imaging 
(MRI) were compatible with polymyositis. Repeat HRCT 
and CXR were compatible with a relapse of an ILD.
Based on the clinical presentation and investigations, 
diagnosis of anti-synthetase syndrome was made. He was 
treated with high dose prednisolone and azathioprine. 
After 1  month of treatment the CPK and inflammatory 
markers normalized.
Discussion
Anti-synthetase syndrome is a rare systemic autoimmune 
syndrome, characterized by the presence of anti-ami-
noacyl-tRNA antibodies (anti-Jo-1) accompanied by a 
constellation of clinical findings including PM-DM, ILD, 
“mechanics hand” appearance, fever and Reynaud’s phe-
nomenon [5–7]. This occurs mainly in adults and more 
common in females and etiology is not known [6]. The 
anti-aminoacyl- tRNA antibodies directed toward the 
attachment of particular amino acid to its transfer RNA 
(tRNA). There are several anti-synthetase antibodies and 
anti-Jo-1 is the commonest and occurs in 80 % of patients 
with anti-synthetase syndrome [8], others are PL-7, 
PL-12, OJ, EJ [6, 7, 9].
Myositis, ILD and joint involvement are the classic 
tried in anti-synthetase syndrome. Myositis occurs in 
more than 90 % of patients and ILD found in more than 
60  % of patients. ILD in anti-synthase syndrome is a 
major cause of morbidity and it can occur in the absence 
of myositis (amyopathic ILD) [7, 8]. Because of this anti-
synthetase antibodies, particularly anti-Jo-1 should be 
performed in all patients with ILD without an obvious 
etiology [8]. Identification of anti-synthetase syndrome 
in patients with amyopathic ILD would be important as 
there are therapeutic implications [7]. Studies have dem-
onstrated the efficacy of immunosuppressive agents in 
ILD associated with anti-synthetase syndrome whereas 
lung transplantation has so far been the only treatment 
option in idiopathic pulmonary fibrosis [7].
Histology may show different patterns including non-
specific interstitial pneumonia (NSIP), diffuse alveolar 
damage (DAD), usual interstitial pneumonia (UIP) or 
organizing pneumonia (OP). The prevalence of these his-
tological features varies between reports and NSIP is the 
commonest pattern [5, 7].
Although OP is commonly seen with rheumatoid 
arthritis (RA), manifesting after the onset of arthritis, it 
is rare with PM-DM and manifests before the onset of 
myositis as in our patient [3]. However organizing pneu-
monia complicating polymyositis carries a better progno-
sis than UIP or DAD [1].
Joint involvement occurs in more than 50 % of patients 
with anti-synthetase syndrome and it can range from 
simple arthralgia to arthritis which can be erosive [6]. 
Fig. 1 HRCT of the chest showing sub pleural patchy airspace 
consolidation and ground glass opacification with airbronchogram in 
bilateral basel regions with sparing of upper and middle zones, which 
was compatible with OP
Fig. 2 Histology of muscle biopsy showing varying sized muscle fib-
ers with focal degenerative and regenerative changes and a chronic 
inflammatory infiltrate destroying myocytes (H&E)
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“Mechanics hands” occurs in 30  % of patients and 
Raynaud phenomenon occurs in 40 % [7].
Although over 90 % patients with polymyositis typically 
present with proximal muscle weakness, mild myalgias 
and muscle tenderness occur in 25–50  % of cases and 
11 % of patients show normal EMG as in our patient [10]. 
Positive anti-Jo-1 antibody, muscle histology and mus-
cle MRI confirmed the diagnosis of polymyositis in this 
patient.
As our patient had positive anti JO-1 antibody together 
with fever, PM and ILD the diagnosis of anti-synthetase 
syndrome was made. At the time of diagnosis Raynaud 
phenomenon, joint involvement, “mechanics hands” 
were absent in our patient but these can be manifested 
later [7].
The presence of Anti-Jo-1 is known to be associated 
with poor survival, lesser response to steroids and a 
higher incidence of flare-ups when steroids are tapered 
off. This patient however responded to steroids and 
is currently stable on a tail off regime of steroids and 
azathioprine.
Conclusion
Organizing pneumonia associated anti-synthetase syn-
drome is a rare finding especially as the first manifes-
tation. This case signifies the importance of screening 
patients with OP and other ILD without obvious etiology 
for anti-synthetase syndrome and arranging long term 
follow-ups [8].
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